MX346640B - Procedimiento de sintesis de derivados de la 7,8-dimetoxi-1,3-dihi dro-2h-3-benzazepin-2-ona y aplicación a la sintesis de la ivabradina. - Google Patents

Procedimiento de sintesis de derivados de la 7,8-dimetoxi-1,3-dihi dro-2h-3-benzazepin-2-ona y aplicación a la sintesis de la ivabradina.

Info

Publication number
MX346640B
MX346640B MX2014003347A MX2014003347A MX346640B MX 346640 B MX346640 B MX 346640B MX 2014003347 A MX2014003347 A MX 2014003347A MX 2014003347 A MX2014003347 A MX 2014003347A MX 346640 B MX346640 B MX 346640B
Authority
MX
Mexico
Prior art keywords
synthesis
ivabradine
application
benzazepin
dimethoxy
Prior art date
Application number
MX2014003347A
Other languages
English (en)
Other versions
MX2014003347A (es
Inventor
Le Flohic Alexandre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MX2014003347A publication Critical patent/MX2014003347A/es
Publication of MX346640B publication Critical patent/MX346640B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedimiento de síntesis del compuesto de fórmula (I): (ver Fórmula) en la que R representa un grupo para-metoxibencilo (PMB) o el grupo siguiente: (ver Fórmula) Aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable.
MX2014003347A 2013-03-26 2014-03-19 Procedimiento de sintesis de derivados de la 7,8-dimetoxi-1,3-dihi dro-2h-3-benzazepin-2-ona y aplicación a la sintesis de la ivabradina. MX346640B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1352741A FR3003859B1 (fr) 2013-03-26 2013-03-26 "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"

Publications (2)

Publication Number Publication Date
MX2014003347A MX2014003347A (es) 2014-09-25
MX346640B true MX346640B (es) 2017-03-27

Family

ID=48613923

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003347A MX346640B (es) 2013-03-26 2014-03-19 Procedimiento de sintesis de derivados de la 7,8-dimetoxi-1,3-dihi dro-2h-3-benzazepin-2-ona y aplicación a la sintesis de la ivabradina.

Country Status (37)

Country Link
US (1) US8927708B2 (es)
EP (1) EP2784066B1 (es)
JP (1) JP5732159B2 (es)
KR (1) KR101616434B1 (es)
CN (1) CN104072420B (es)
AR (1) AR095722A1 (es)
AU (1) AU2014201355B2 (es)
BR (1) BR102014007079A2 (es)
CA (1) CA2846917C (es)
CY (1) CY1116535T1 (es)
DK (1) DK2784066T3 (es)
EA (1) EA025516B1 (es)
ES (1) ES2548713T3 (es)
FR (1) FR3003859B1 (es)
GE (1) GEP201706731B (es)
HK (2) HK1198366A1 (es)
HR (1) HRP20150924T1 (es)
HU (1) HUE025550T2 (es)
IN (1) IN2014DE00793A (es)
JO (1) JO3132B1 (es)
MA (1) MA35509B1 (es)
MD (1) MD4461C1 (es)
ME (1) ME02213B (es)
MX (1) MX346640B (es)
MY (1) MY189537A (es)
NZ (1) NZ622915A (es)
PL (1) PL2784066T3 (es)
PT (1) PT2784066E (es)
RS (1) RS54186B1 (es)
SA (1) SA114350383B1 (es)
SG (1) SG10201400610SA (es)
SI (1) SI2784066T1 (es)
TW (1) TWI511957B (es)
UA (1) UA116527C2 (es)
UY (1) UY35503A (es)
WO (1) WO2014154994A1 (es)
ZA (1) ZA201402072B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104610146A (zh) * 2015-01-23 2015-05-13 常州大学 一种3-氮杂二环[5,1,0]-7-醛及合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
DE3343801A1 (de) * 1983-12-03 1985-06-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue indolderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3519735A1 (de) * 1985-06-01 1986-12-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
GB0412314D0 (en) * 2004-06-02 2004-07-07 Glaxo Group Ltd Compounds
US8312771B2 (en) 2006-11-10 2012-11-20 Siemens Medical Solutions Usa, Inc. Transducer array imaging system
EP2097383B1 (en) * 2006-11-30 2012-02-08 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
FR2920773B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN101343249A (zh) * 2008-06-10 2009-01-14 上海医药工业研究院 3－(3－氯丙基)－7,8－二甲氧基－1,3－二氢－2h－3－苯并氮杂－2－酮的制备方法
FR2932800B1 (fr) * 2008-06-20 2015-02-20 Servier Lab Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2941695B1 (fr) * 2009-02-04 2011-02-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
TWI511957B (zh) 2015-12-11
EP2784066B1 (fr) 2015-07-01
SI2784066T1 (sl) 2015-10-30
AR095722A1 (es) 2015-11-04
GEP201706731B (en) 2017-09-11
MD4461B1 (ro) 2017-01-31
EP2784066A1 (fr) 2014-10-01
EA025516B1 (ru) 2016-12-30
FR3003859A1 (fr) 2014-10-03
ZA201402072B (en) 2015-03-25
WO2014154994A1 (fr) 2014-10-02
SA114350383B1 (ar) 2015-10-08
RS54186B1 (en) 2015-12-31
CN104072420B (zh) 2016-09-28
MA35509B1 (fr) 2014-10-02
MD20140028A2 (ro) 2014-09-30
MY189537A (en) 2022-02-16
CN104072420A (zh) 2014-10-01
AU2014201355B2 (en) 2017-08-24
ME02213B (me) 2016-02-20
HRP20150924T1 (hr) 2015-10-09
UY35503A (es) 2014-10-31
ES2548713T3 (es) 2015-10-20
FR3003859B1 (fr) 2015-03-13
KR20140117298A (ko) 2014-10-07
PT2784066E (pt) 2015-08-31
JO3132B1 (ar) 2017-09-20
DK2784066T3 (en) 2015-10-05
US8927708B2 (en) 2015-01-06
NZ622915A (en) 2015-05-29
HUE025550T2 (en) 2016-02-29
SG10201400610SA (en) 2014-10-30
AU2014201355A1 (en) 2014-10-16
BR102014007079A2 (pt) 2015-10-20
KR101616434B1 (ko) 2016-04-28
HK1202532A1 (en) 2015-10-02
EA201400269A1 (ru) 2014-09-30
MD4461C1 (ro) 2017-08-31
MX2014003347A (es) 2014-09-25
IN2014DE00793A (es) 2015-06-12
CY1116535T1 (el) 2017-03-15
CA2846917C (fr) 2016-02-09
PL2784066T3 (pl) 2015-11-30
US20140296512A1 (en) 2014-10-02
HK1198366A1 (en) 2015-04-10
UA116527C2 (uk) 2018-04-10
JP5732159B2 (ja) 2015-06-10
JP2014196299A (ja) 2014-10-16
CA2846917A1 (fr) 2014-09-26
TW201522313A (zh) 2015-06-16

Similar Documents

Publication Publication Date Title
PH12017501429A1 (en) Derivatives of betulin
PH12016500169A1 (en) Polymorph of syk inhibitors
IN2014MN02106A (es)
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
MY187718A (en) Pharmaceutical formulations
MX362383B (es) Moduladores de acido oxabiciclo[2.2.2] gpr120.
UA101091C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
IN2014CN04449A (es)
MX364400B (es) Compuestos de tetraciclina.
GT201300064A (es) Monohidrato de derivados de aza-adamantano
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
MX362919B (es) Moduladores del receptor acoplado a proteína-g 120 (gpr120) de ácido biciclo-[2.2.1].
MX2010003213A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
UA106386C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
WO2014087208A3 (en) A process of preparing alcaftadine
MX337997B (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
MX2010003184A (es) Nuevo procedimiento de sinstesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX2016005287A (es) Metodos para el tratamiento de distrofias musculares.
CY1116253T1 (el) Νεα μεθοδος συνθεσης του (2ε)-3-(3,4-διμεθοξυφαινυλ)προπ-2-ενονιτριλιου και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
MX346640B (es) Procedimiento de sintesis de derivados de la 7,8-dimetoxi-1,3-dihi dro-2h-3-benzazepin-2-ona y aplicación a la sintesis de la ivabradina.
UY35561A (es) Procedimiento de síntesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7- carbonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
EA201791098A1 (ru) Способ синтеза производных бензазепина
IN2013CN00515A (es)

Legal Events

Date Code Title Description
FG Grant or registration